DK1614687T3 - Fremgangsmåde til fremstilling af 1,3,4,5-tetrahydro-2H-3-benzazepin-2-onderivater og deres anvendelse ved syntese af ivabradin og farmaceutisk acceptable salte deraf - Google Patents

Fremgangsmåde til fremstilling af 1,3,4,5-tetrahydro-2H-3-benzazepin-2-onderivater og deres anvendelse ved syntese af ivabradin og farmaceutisk acceptable salte deraf

Info

Publication number
DK1614687T3
DK1614687T3 DK05290383.8T DK05290383T DK1614687T3 DK 1614687 T3 DK1614687 T3 DK 1614687T3 DK 05290383 T DK05290383 T DK 05290383T DK 1614687 T3 DK1614687 T3 DK 1614687T3
Authority
DK
Denmark
Prior art keywords
ivabradine
benzazepine
tetrahydro
synthesis
derivatives
Prior art date
Application number
DK05290383.8T
Other languages
English (en)
Inventor
Jean-Michel Lerestif
Jean-Pierre Lecouve
Jean-Claude Souvie
Daniel Brigot
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1614687T3 publication Critical patent/DK1614687T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
DK05290383.8T 2004-04-13 2005-02-21 Fremgangsmåde til fremstilling af 1,3,4,5-tetrahydro-2H-3-benzazepin-2-onderivater og deres anvendelse ved syntese af ivabradin og farmaceutisk acceptable salte deraf DK1614687T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0403828A FR2868775B1 (fr) 2004-04-13 2004-04-13 Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Publications (1)

Publication Number Publication Date
DK1614687T3 true DK1614687T3 (da) 2010-03-29

Family

ID=34941961

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05290383.8T DK1614687T3 (da) 2004-04-13 2005-02-21 Fremgangsmåde til fremstilling af 1,3,4,5-tetrahydro-2H-3-benzazepin-2-onderivater og deres anvendelse ved syntese af ivabradin og farmaceutisk acceptable salte deraf

Country Status (33)

Country Link
US (1) US7064200B2 (da)
EP (1) EP1614687B1 (da)
JP (2) JP4515933B2 (da)
KR (1) KR100636499B1 (da)
CN (1) CN100348585C (da)
AR (1) AR047707A1 (da)
AT (1) ATE448221T1 (da)
AU (1) AU2005200884B2 (da)
BR (1) BRPI0500590B8 (da)
CA (1) CA2496712C (da)
CY (1) CY1109740T1 (da)
DE (1) DE602005017541D1 (da)
DK (1) DK1614687T3 (da)
EA (1) EA007743B1 (da)
EG (1) EG25619A (da)
ES (1) ES2336461T3 (da)
FR (1) FR2868775B1 (da)
GE (1) GEP20074136B (da)
HK (1) HK1079777A1 (da)
HR (1) HRP20100024T1 (da)
MA (1) MA27598A1 (da)
MX (1) MXPA05003696A (da)
MY (1) MY140904A (da)
NO (1) NO329861B1 (da)
NZ (1) NZ538328A (da)
PL (1) PL1614687T3 (da)
PT (1) PT1614687E (da)
RS (1) RS51232B (da)
SG (1) SG116574A1 (da)
SI (1) SI1614687T1 (da)
UA (1) UA81773C2 (da)
WO (1) WO2005111027A1 (da)
ZA (1) ZA200501468B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2868775B1 (fr) * 2004-04-13 2008-04-11 Servier Lab Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
GT200500185A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
RU2473544C2 (ru) 2007-05-30 2013-01-27 Инд-Свифт Лабораториз Лимитед Способ получения ивабрадина гидрохлорида и его полиморфных модификаций
WO2010072409A1 (en) 2008-12-22 2010-07-01 Krka, D. D., Novo Mesto Process for preparation of ivabradine
FR2940287B1 (fr) * 2008-12-24 2010-12-24 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
PL2902384T3 (pl) 2010-02-12 2018-04-30 Krka, D.D., Novo Mesto Postać chlorowodorku iwabradyny
FR2956401B1 (fr) * 2010-02-17 2012-02-03 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2971507B1 (fr) * 2011-02-14 2013-01-18 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984320B1 (fr) * 2011-12-20 2013-11-29 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2993561B1 (fr) * 2012-07-17 2014-10-31 Servier Lab Procede de synthese enzymatique de la (7s)-1-(3,4-dimethoxy bicyclo[4.2.0]octa-1,3,5-triene 7-yl) n-methyl methanamine, et application a la synthese de l'ivabradine et de ses sels
FR3003859B1 (fr) * 2013-03-26 2015-03-13 Servier Lab "procede de synthese de derives de la 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one et application a la synthese de l'ivabradine"

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3418270A1 (de) * 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach Neue aminotetralinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3519735A1 (de) * 1985-06-01 1986-12-04 Dr. Karl Thomae Gmbh, 7950 Biberach Neue heteroaromatische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0204349A3 (de) * 1985-06-01 1990-01-03 Dr. Karl Thomae GmbH Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868775B1 (fr) * 2004-04-13 2008-04-11 Servier Lab Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Also Published As

Publication number Publication date
CN1683343A (zh) 2005-10-19
JP2010047577A (ja) 2010-03-04
AU2005200884A1 (en) 2005-10-27
MA27598A1 (fr) 2005-11-01
KR100636499B1 (ko) 2006-10-18
ZA200501468B (en) 2005-11-30
PT1614687E (pt) 2009-12-02
PL1614687T3 (pl) 2010-04-30
HK1079777A1 (en) 2006-04-13
GEP20074136B (en) 2007-06-25
RS51232B (sr) 2010-12-31
US7064200B2 (en) 2006-06-20
WO2005111027A1 (fr) 2005-11-24
MY140904A (en) 2010-01-29
NO20050888L (no) 2005-10-14
EA200500240A1 (ru) 2005-10-27
NO329861B1 (no) 2011-01-17
EP1614687B1 (fr) 2009-11-11
SI1614687T1 (sl) 2010-01-29
JP4515933B2 (ja) 2010-08-04
CY1109740T1 (el) 2014-09-10
DE602005017541D1 (de) 2009-12-24
CA2496712C (fr) 2010-04-06
KR20060042117A (ko) 2006-05-12
NO20050888D0 (no) 2005-02-18
NZ538328A (en) 2005-10-28
JP5277130B2 (ja) 2013-08-28
AR047707A1 (es) 2006-02-08
SG116574A1 (en) 2005-11-28
EG25619A (en) 2012-03-26
BRPI0500590B8 (pt) 2021-05-25
HRP20100024T1 (hr) 2010-02-28
ATE448221T1 (de) 2009-11-15
JP2005298478A (ja) 2005-10-27
UA81773C2 (uk) 2008-02-11
CA2496712A1 (fr) 2005-10-13
FR2868775A1 (fr) 2005-10-14
BRPI0500590A (pt) 2005-11-16
ES2336461T3 (es) 2010-04-13
BRPI0500590B1 (pt) 2018-10-09
CN100348585C (zh) 2007-11-14
EA007743B1 (ru) 2006-12-29
AU2005200884B2 (en) 2010-07-15
EP1614687A1 (fr) 2006-01-11
MXPA05003696A (es) 2006-01-24
US20050228178A1 (en) 2005-10-13
FR2868775B1 (fr) 2008-04-11

Similar Documents

Publication Publication Date Title
DK1614687T3 (da) Fremgangsmåde til fremstilling af 1,3,4,5-tetrahydro-2H-3-benzazepin-2-onderivater og deres anvendelse ved syntese af ivabradin og farmaceutisk acceptable salte deraf
DK1589005T3 (da) Fremgangsmåde til syntese af ivabradin og additionssalte heraf med en farmaceutisk acceptabel syre
EG23719A (en) New process for the synthesis of (I S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane and addition salts thereof, and application in the synthesis of I V abradine and addition salts thereof witha pharmaceutically acceptable acid
IL192241A (en) A process for making 4 - (benzimidazolylmethylamino) - benzamides and their salts
HK1095146A1 (en) Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
NO20054905D0 (no) 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
DK1575565T3 (da) Tablet med modificeret frigivelse af bupropion-hydrochlorid
DK1268424T3 (da) Fremgangsmåde til syntese af perindopril og dets farmaceutisk acceptable salte
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
DK1564204T3 (da) Ny fremgangsmåde til fremstilling af (7-methoxy-3,4-dihydro-1-naphthalenyl) acetonitril og anvendelse heraf ved syntese af agomelatin
ZA200702596B (en) Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
NO20053809D0 (no) Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
DK2152654T3 (da) 4-chlor-4-alkoxy-1,1,1-trifluor-2-butanoner, fremstilling heraf og deres anvendelse ved fremstilling af 4-alkoxy-1,1,1-trifluor-3-buten-2-oner
DK1589014T3 (da) Fremgangsmåde til syntese af derivater af 1,3-dihydro-2H-3-benzazepin-2-on og anvendelse heraf ved syntese af ivabradin og additionssalte heraf med en farmaceutisk acceptabel syre
HK1102395A1 (en) Indene derivatives and process for the preparation thereof
DK1753720T3 (da) Fremgangsmåde til fremstilling af perindopril og salte deraf
DK1420028T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1367061T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
EP1756036A4 (en) INDENED DERIVATIVES AND PROCESS FOR THEIR PREPARATION
EP1866303A4 (en) METHOD AND METHOD FOR THE PRODUCTION OF OPTICALLY ACTIVE CIS-2-HYDROXYMETHYL-4- (CYTOSIN-1-YL) -1,3-OXATHIOLAN OR PHARMACEUTICALALLY SALTS THEREOF
DK1371659T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
HK1100946A1 (en) 1-a-HALO-2,2-DIFLUORO-2-DEOXY-D-RIBOFURANOSE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
EP1900735A4 (en) PYRIDAZINYLAMINE DERIVATIVES, USE OF DERIVATIVES IN THE PREPARATION OF PICORNAVIRUS INHIBITORS
SI1747201T1 (sl) Derivati 2H- ali 3-H-benzo (e)indazol-1-il karbamata, njihova priprava in njihova terapevtska uporaba
DK1420029T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf